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MCF-7	 n.d.	 244.7±9.5	µM	 10.6±2.6	µM	 12.6±2.8	µM	
MDA-MB-231	 n.d.	 273.3±32.2	µM	 9.5±3.9	µM	 3.7±3.3	µM	
MDA-MB-468	 n.d.	 188.5±124.4	µM	 n.d.	 4.8±1.4	µM	
MCF-10A	 n.d.	 142.0±87.4	µM	 2.6±2.6	µM	 3.8±1.1	µM	
	n.d.	=	not	determined	as	slope	did	not	converge	
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Figure	1:	The	FXR	agonists	GW4064	and	CDCA	cause	concentration-dependent	toxicity	in	
breast	cancer	cell	lines.	MCF-10A	(A),	MCF-7	(B),	MDA-MB-231	(C)	and	MDA-MB-468	(D)	
cells	were	exposed	to	varying	concentrations	of	GW4064	or	CDCA	in	complete	or	serum-free	
medium.	Following	48	or	72	hours	of	exposure,	cell	viability	was	assessed	by	MTT.	Each	data	
point	represents	the	mean	of	three	independent	experiments,	while	error	bars	represent	
the	standard	error	of	the	mean	(SEM).	*	=	p<0.05,	**	=	p<0.01,	***	=	p<0.001	
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Figure	2:	The	FXR	agonists	GW4064	and	CDCA	cause	concentration-dependent	activation	
of	caspase	3	and	caspase	7	in	the	MCF-7	and	MDA-MB-231	cell	lines.	(A)	MCF-7	and	MDA-
MB-231	cells	were	exposed	to	3µM	GW4064,	30µM	CDCA,	or	1µM	staurosporine	in	serum-
free	medium,	in	the	presence	or	absence	of	specific	caspase	inhibitors	for	24	hours,	and	
then	Caspase	3	and	caspase	7	activity	measured.	(B)	MCF-7	and	MDA-MB-231	cells	were	
exposed	to	indicated	concentrations	of	GW4064,	CDCA	or	staurosporine	in	serum-free	
medium	for	24	hours	and	then	poly(ADP-ribose)polymerase-1		(PARP)	cleavage	assessed	by	
Western	blot.	Each	data	point	represents	the	mean	of	three	independent	experiments,	
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while	error	bars	represent	the	standard	error	of	the	mean	(SEM).	*	=	p<0.05,	**	=	p<0.01,	
***	=	p<0.001	
	
	
Figure	3:	The	FXR	agonists	GW4064	and	CDCA	activate	caspase	9,	but	not	caspase	8,	
activity	in	the	MCF-7	and	MDA-MB-231	cell	lines.	MCF-7	and	MDA-MB-231	cells	were	
exposed	to	3µM	GW4064,	30	µM	CDCA	or	1µM	staurosporine	in	serum-free	medium	for	24	
hours,	and	then	Caspase	8	and	caspase	9	activity	measured.	Each	data	point	represents	the	
mean	of	three	independent	experiments,	while	error	bars	represent	the	standard	error	of	
the	mean	(SEM).	*	=	p<0.05,	**	=	p<0.01,	***	=	p<0.001	
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Figure	4:	The	FXR	agonists	GW4064	and	CDCA	stimulate	apoptosis	through	the	intrinsic	
pathway	in	MCF-7	and	MDA-MB-231	cell	lines.	MCF-7	and	MDA-MB-231	cells	were	
exposed	to	3µM	GW4064,	30	µM	CDCA	or	1µM	staurosporine	in	serum-free	medium.	(A)	
Subcellular	localisation	of	cytochrome	c	was	examined	following	0,	4,	6	and	8	hours	of	
exposure,	with	LDH	as	a	marker	for	the	cytosolic	fraction.	(B)	Bax	and	Bcl2	protein	levels	
were	measured	in	total	protein	following	24	hours	of	exposure.	Each	data	point	represents	
the	mean	of	three	independent	experiments,	while	error	bars	represent	the	standard	error	
of	the	mean	(SEM).	*	=	p<0.05,	**	=	p<0.01,	***	=	p<0.001	
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Figure	5:	The	FXR	agonist	GW4064	stimulates	autophagy	in	MCF-7	cells.	MCF-7	and	MDA-
MB-231	cells	were	exposed	to	3µM	GW4064	or	30	µM	CDCA	in	serum-free	medium	for	24	
hours	and	autophagy	assessed	by	(A)	LC3	cleavage	and	(B)	p62/SQSTM1	accumulation.	5mM	
3-methyladenine	and	2.5µM	rapamycin	were	included	where	indicated	as	an	inhibitor	and	
activator	of	autophagy,	respectively.	Each	data	point	represents	the	mean	of	three	
independent	experiments,	while	error	bars	represent	the	standard	error	of	the	mean	(SEM).	
*	=	p<0.05,	***	=	p<0.001	
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Figure	6:	Induction	of	apoptosis	and	autophagy	in	breast	cancer	cell	lines	by	GW6064	and	
CDCA	is	FXR-dependent.	MCF-7	and	MDA-MB-231	cells	were	exposed	to	GW4064	or	CDCA	
in	serum-free	medium	for	24	hours	in	the	presence	or	absence	of	a	dominant	negative	FXR	
protein	(FXR-DN).	(A)	Cells	were	exposed	to	3µM	GW4064	or	30	µM	CDCA		and	expression	
of	the	FXR	target	gene	SHP	monitored	by	Western	blotting.	(B)	Cells	were	exposed	to	IC50	
concentration	of	GW4064	or	CDCA	and	cell	viability	assessed	by	MTT	assay.	(C)	Cells	were	
exposed	to	3µM	GW4064	or	30	µM	CDCA	and	apoptosis	assessed	by	caspase	3/7	activity	
assay.	(D)	Cells	were	exposed	to	3µM	GW4064	or	30	µM	CDCA	and	autophagy	assessed	by	
p62/SQSTM1	accumulation.	Each	data	point	represents	the	mean	of	three	independent	
experiments,	while	error	bars	represent	the	standard	error	of	the	mean	(SEM).	*	=	p<0.05,	
**	=	p<0.01,	***	=	p<0.001	
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Figure	7:	The	FXR	agonists	GW4064	and	CDCA	do	not	stimulate	migration	of	MCF-7	or	
MDA-MB-231	cell	lines.	(A)	MCF-7	and	MDA-MB-231	cells	were	seeded	in	transwell	plates	
and	exposed	to	3µM	GW4064	or	30	µM	CDCA	in	serum-free	medium	for	72	hours.	The	
number	of	cells	migrating	into	the	bottom	chamber	was	quantified.	(B)		MCF-7	and	MDA-
MB-231	cells	were	seeded	in	a	wound-healing	assay	format	and	exposed	to	3µM	GW4064	or	
30	µM	CDCA	in	serum-free	medium	for	24	hours.	Cell	migration	was	quantified	by	closure	of	
the	scratch	area	using	the	tScatch	program.	Each	data	point	represents	the	mean	of	three	
independent	experiments,	while	error	bars	represent	the	standard	error	of	the	mean	(SEM).	
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Supplementary	Figure	1:	Breast	cancer	cell	lines	express	a	functional	FXR	gene	regulatory	
network	
	
	
Figure	S1:	Breast	cancer	cell	lines	express	a	functional	FXR	gene	regulatory	network.	(A)	
MCF-10A,	MCF-7,	MDA-MB-231	and	MDA-MB-468	cells	were	exposed	to	3µM	GW4064,	
30µM	CDCA	or	vehicle	control	in	serum-free	medium	for	24	hours,	and	then	Farnesoid	X-
receptor	(FXR)	expression	assessed	by	Western	blot.	(B)	MCF-7,	MDA-MB-231	or	HepG2	
(positive	control)	cells	were	exposed	to	3µM	GW4064,	30µM	CDCA	or	vehicle	control	in	
serum-free	medium	for	24	hours,	and	then	small	heterodimer	partner	(SHP)	expression	
assessed	by	Western	blot.	Each	data	point	represents	the	mean	of	three	independent	
experiments,	while	error	bars	represent	the	standard	error	of	the	mean	(SEM).	**	=	p<0.01,	
***	=	p<0.001	
	
32	
	
Supplementary	Figure	S2:	The	FXR	agonists	GW4064	and	CDCA	do	not	stimulate	migration	
of	MCF-10A	or	MDA-MB-468	cell	lines	
	
	
Figure	S2:	The	FXR	agonists	GW4064	and	CDCA	do	not	stimulate	migration	of	MCF-10A	or	
MDA-MB-468	cell	lines.	(A)	MCF-10A	and	MDA-MB-468	cells	were	seeded	in	transwell	
plates	and	exposed	to	3µM	GW4064	or	30	µM	CDCA	in	serum-free	medium	for	72	hours.	
The	number	of	cells	migrating	into	the	bottom	chamber	was	quantified.	(B)		MCF-7	and	
MDA-MB-231	cells	were	seeded	in	a	wound-healing	assay	format	and	exposed	to	3µM	
GW4064	or	30	µM	CDCA	in	serum-free	medium	for	24	hours.	Cell	migration	was	quantified	
by	closure	of	the	scratch	area	using	the	tScatch	program.	Each	data	point	represents	the	
mean	of	three	independent	experiments,	while	error	bars	represent	the	standard	error	of	
the	mean	(SEM).	
	
	
